injection and added to compatible I.V. solution for further dilution. To reconstitute and administer ADD-Vantage systems, follow manufacturer's instructions. Infuse drug over 15 to 30 minutes. • Use diluted solution immediately, if possible. Adverse reactions CNS: headache, insomnia, dizziness, ...
meropenem for injection 药品简介 注射用美罗培南原研产品meropen由日本住友制药株式会社研发,最早于1994年在意大利上市。 基本信息 活性成分(中) 美罗培南 活性成分(英) meropenem 全球最高研发状态 上市 中国最高研发状态 上市 原研公司 sumitomo dainippon pharma co., ltd. 中国首次上市年份 / 首次上市国家 / ...
Generic Name Meropenem For Injection 1g Strength 1g Packing 1vial+10ml WFI/box Origin China Component: Meropenem For Injection 1g. Character: This product is white or white crystalline powder; Odorless. Indications: Meropenem is indicated for the following infections in adults and chi...
Meropenem, like imipenem, is highly resistant to hydrolysis by most of the serine-based β-lactamases produced by Gram-negative bacteria; however, both drugs are susceptible to the metallo-β-lactamases and clavulanic acid-inhibited carbapenemases produced byS. maltophiliaand someFlavobacteriumspp. Hyper...
戊戌数据药品标准数据库提供了Meropenem for Injection注射用美罗培南美国药典标准的查询检索,包括Meropenem for Injection注射用美罗培南美国药典的版本USP35-NF30页码,以及药典的查询与下载.
All rats underwent laparotomy with cannulation of biliopancreatic duct. Group 1 received intraductal saline injection. Acute necrotizing pancreatitis was induced in group 2, 3, 4, and 5 by intraductal injection of 3% taurocholate. Group 1 (sham operated) and group 2 were injected with saline of...
The invention provides a stable meropenem injection and a preparation method thereof. The injection is liposome freeze-dried preparation, which comprises the following components by weight: 5 to 15 parts of meropenem, 80 to 160 parts of phosphatide, 50 to 110 parts of cholesterol, 0.15 to 0.50...
英文名:Meropenem For Injection 商品名:Merrem Iv 规格:0.5g;1g 持证商:Pfizer Limited 上市国:美国 广东宝康药业有限公司,成立于2001年,是一家为客户提供产品信息查询、供应商筛选、进口注册备案、进口通关等一站式进口服务的企业。公司始终坚持“合法合规、价低质优、专业快速”理念,并凭借十八年来积累的进口...
Meropenem (Merrem®, Meronem®) is a broad-spectrum antibacterial agent of the carbapenem family, indicated as empirical therapy prior to the ident
Meropenem injection Specification:0.5g; 0.25g. Solution preparation: After dilution with a suitable solution, within 15 to 30 min, apply intravenous infusion or intravenous injection via dilution with sterile water in 3-5 minutes. Adult Intravenous administration: General dose: administer of 500 mg-...